Samsara Therapeutics Company
Samsara Therapeutics, Inc. is an R&D-stage biopharmaceutical platform company aiming to discover, develop and commercialize therapeutics for the treatment of unmet medical needs and age-related diseases. Samsara's platform is a pipeline for the identification, chemical optimization, and in vivo validation of compounds that extend a healthy lifespan.
Founded Date:
2018-01-01
Last Funding Type:
Series A
Headquarters:
Boston, Massachusetts, United States
Investors Number:
2
Technology:
Geroscience
Employee Number:
1-10
Industry:
Pharmtech
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021
Number Of Exists:
Seed
Funding Status:
Early Stage Venture
Investor Type:
Company
Total Funding:
13513498